Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The medication is administered via weekly injections and has demonstrated remarkable weight loss results compared to other treatments
Beyond gastrointestinal symptoms, other adverse effects observed in trials include injection site reactions (such as redness, bruising, or mild swelling), fatigue, dizziness, and small mean increases in heart rate
The pharmacokinetics of retatrutide are dose-proportional, with a half-life of approximately 6 days, making weekly dosing feasible [113]
Contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, active pancreatitis, or severe dehydration
US$ 23.63
US$ 20.79
US$ 25.60
